Finally, a schematic model (Figure 5I) summarizes our findings, suggesting that complement activation, particularly through C3, enhances the expression of inflammatory markers such as IL6 and CRP, thereby contributing to the inflammatory milieu associated with PCOS. This evidence concerns the gene C3 and polycystic ovary syndrome.